Access
To read this story in full you will need to login or make a payment (see right).
News and Views
Nature 446, 739-740 (12 April 2007) | doi:10.1038/446739a; Published online 11 April 2007
Open Innovation Challenges
- More Challenges
- Powered by:
nature jobs
Assistant Professor and Associate Professor
- Massachusetts General Hospital/ Harvard Medical School
- Charlestown, MA
Group Leader Positions
- IMP
- Vienna Austria
Genomics: Global views of leukaemia
Todd R. Golub1
Abstract
Genomic characterization of a type of leukaemia has resulted in the identification of common genetic abnormalities that underlie the disease. The results constitute an advance on several fronts.
It is now widely acknowledged that cancer is a genetic disease, caused largely by the acquisition of mutations in somatic (non-germline) cells after birth — or in some cases during fetal development. A systematic search for these mutations was previously impossible, but progress in genomics technology holds the promise of making the complete characterization of the 'cancer genome' feasible.
- Todd R. Golub is at the Broad Institute of Harvard and the Massachusetts Institute of Technology; and the Dana-Farber Cancer Institute, 7 Cambridge Center, Cambridge, Massachusetts 02142, USA.
Email: golub@broad.harvard.edu
To read this story in full you will need to login or make a payment (see right).
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated.
RESEARCH
Fission yeast Mes1p ensures the onset of meiosis II by blocking degradation of cyclin Cdc13pNature Letters to Editor (24 Mar 2005)
